170 related articles for article (PubMed ID: 29049980)
1. The dual role of poly(ADP-ribose) polymerase-1 in modulating parthanatos and autophagy under oxidative stress in rat cochlear marginal cells of the stria vascularis.
Jiang HY; Yang Y; Zhang YY; Xie Z; Zhao XY; Sun Y; Kong WJ
Redox Biol; 2018 Apr; 14():361-370. PubMed ID: 29049980
[TBL] [Abstract][Full Text] [Related]
2. PARP1 inhibition prevents oxidative stress in age-related hearing loss via PAR-Ca
Wan H; Chen H; Liu J; Yang B; Zhang Y; Bai Y; Chen X; Wang J; Liu T; Zhang Y; Hua Q
Free Radic Biol Med; 2024 Aug; 220():222-235. PubMed ID: 38735540
[TBL] [Abstract][Full Text] [Related]
3. Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunities.
Xu X; Sun B; Zhao C
Neurobiol Dis; 2023 Oct; 187():106314. PubMed ID: 37783233
[TBL] [Abstract][Full Text] [Related]
4. The 89-kDa PARP1 cleavage fragment serves as a cytoplasmic PAR carrier to induce AIF-mediated apoptosis.
Mashimo M; Onishi M; Uno A; Tanimichi A; Nobeyama A; Mori M; Yamada S; Negi S; Bu X; Kato J; Moss J; Sanada N; Kizu R; Fujii T
J Biol Chem; 2021; 296():100046. PubMed ID: 33168626
[TBL] [Abstract][Full Text] [Related]
5. Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities.
Fatokun AA; Dawson VL; Dawson TM
Br J Pharmacol; 2014 Apr; 171(8):2000-16. PubMed ID: 24684389
[TBL] [Abstract][Full Text] [Related]
6. Non-apoptotic regulated cell death in Fuchs endothelial corneal dystrophy.
Sakakura S; Inagaki E; Sayano T; Yamazaki R; Fusaki N; Hatou S; Hirayama M; Tsubota K; Negishi K; Okano H; Shimmura S
Regen Ther; 2023 Dec; 24():592-601. PubMed ID: 38034859
[TBL] [Abstract][Full Text] [Related]
7. The key players of parthanatos: opportunities for targeting multiple levels in the therapy of parthanatos-based pathogenesis.
Liu L; Li J; Ke Y; Zeng X; Gao J; Ba X; Wang R
Cell Mol Life Sci; 2022 Jan; 79(1):60. PubMed ID: 35000037
[TBL] [Abstract][Full Text] [Related]
8. Crocetin antagonizes parthanatos in ischemic stroke via inhibiting NOX2 and preserving mitochondrial hexokinase-I.
Wu H; Li Y; Zhang Q; Wang H; Xiu W; Xu P; Deng Y; Huang W; Wang DO
Cell Death Dis; 2023 Jan; 14(1):50. PubMed ID: 36681688
[TBL] [Abstract][Full Text] [Related]
9. Exploring the role of parthanatos in CNS injury: Molecular insights and therapeutic approaches.
Zhang J; Hu X; Geng Y; Xiang L; Wu Y; Li Y; Yang L; Zhou K
J Adv Res; 2024 May; ():. PubMed ID: 38704090
[TBL] [Abstract][Full Text] [Related]
10. CASK Mediates Oxidative Stress-Induced Microglial Apoptosis-Inducing Factor-Independent Parthanatos Cell Death via Promoting PARP-1 Hyperactivation and Mitochondrial Dysfunction.
Cheong KJH; Huang DY; Sekar P; Chen RJ; Cheng IH; Chan CM; Chen YS; Lin WW
Antioxidants (Basel); 2024 Mar; 13(3):. PubMed ID: 38539876
[TBL] [Abstract][Full Text] [Related]
11. Activated SIRT1 contributes to DPT-induced glioma cell parthanatos by upregulation of NOX2 and NAT10.
Liang SP; Wang XZ; Piao MH; Chen X; Wang ZC; Li C; Wang YB; Lu S; He C; Wang YL; Chi GF; Ge PF
Acta Pharmacol Sin; 2023 Oct; 44(10):2125-2138. PubMed ID: 37277492
[TBL] [Abstract][Full Text] [Related]
12. Bi-directional regulation of AIMP2 and its splice variant on PARP-1-dependent neuronal cell death; Therapeutic implication for Parkinson's disease.
Lee MH; Um KH; Lee SW; Sun YJ; Gu DH; Jo YO; Kim SH; Seol W; Hwang H; Baek K; Choi JW
Acta Neuropathol Commun; 2024 Jan; 12(1):5. PubMed ID: 38172953
[TBL] [Abstract][Full Text] [Related]
13. Synaptic vesicle protein 2A mitigates parthanatos via apoptosis-inducing factor in a rat model of pharmacoresistant epilepsy.
Li C; Wang Z; Ren M; Ren S; Wu G; Wang L
CNS Neurosci Ther; 2024 May; 30(5):e14778. PubMed ID: 38801174
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol Preconditioning Downregulates PARP1 Protein to Alleviate PARP1-Mediated Cell Death Following Cerebral Ischemia.
Jackson CW; Xu J; Escobar I; Saul I; Fagerli E; Dave KR; Perez-Pinzon MA
Transl Stroke Res; 2024 Feb; 15(1):165-178. PubMed ID: 36633794
[TBL] [Abstract][Full Text] [Related]
15. Parthanatos: Mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke.
Yang L; Guttman L; Dawson VL; Dawson TM
Biochem Pharmacol; 2024 Mar; ():116174. PubMed ID: 38552851
[TBL] [Abstract][Full Text] [Related]
16. Drug antagonism and single-agent dominance result from differences in death kinetics.
Richards R; Schwartz HR; Honeywell ME; Stewart MS; Cruz-Gordillo P; Joyce AJ; Landry BD; Lee MJ
Nat Chem Biol; 2020 Jul; 16(7):791-800. PubMed ID: 32251407
[TBL] [Abstract][Full Text] [Related]
17. Stanniocalcin-1 Promotes PARP1-Dependent Cell Death via JNK Activation in Colitis.
Zhu L; Xie Z; Yang G; Zhou G; Li L; Zhang S
Adv Sci (Weinh); 2024 Feb; 11(5):e2304123. PubMed ID: 38088577
[TBL] [Abstract][Full Text] [Related]
18. Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists.
Morris G; Walker AJ; Berk M; Maes M; Puri BK
Mol Neurobiol; 2018 Jul; 55(7):5767-5786. PubMed ID: 29052145
[TBL] [Abstract][Full Text] [Related]
19. Regulatory role of calpain in neuronal death.
Cheng SY; Wang SC; Lei M; Wang Z; Xiong K
Neural Regen Res; 2018 Mar; 13(3):556-562. PubMed ID: 29623944
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson's disease.
Kam TI; Mao X; Park H; Chou SC; Karuppagounder SS; Umanah GE; Yun SP; Brahmachari S; Panicker N; Chen R; Andrabi SA; Qi C; Poirier GG; Pletnikova O; Troncoso JC; Bekris LM; Leverenz JB; Pantelyat A; Ko HS; Rosenthal LS; Dawson TM; Dawson VL
Science; 2018 Nov; 362(6414):. PubMed ID: 30385548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
